Dolby Laboratories Share Price Today
(NASDAQ: DLB)

Name: Dolby Laboratories Share Price Today (NASDAQ: DLB) - Dolby Laboratories Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Dolby Laboratories share price is $82.2 & ₹7,148.85 as on 6 Mar 2025, 2.30 'hrs' IST

$82.2

▲

1.56

(1.93%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Dolby Laboratories share price in Dollar and Rupees. Guide to invest in Dolby Laboratories stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Dolby Laboratories, along with analyst recommendations, forecasts, and comprehensive financials.

Dolby Laboratories share price movements

Today's Low: $80.35
Today's High: $82.25
$82.20
2.25%
Downside
Day's Volatility :2.31%
Upside
0.06%
52 Weeks Low: $66.35
52 Weeks High: $89.66
$82.20
19.28%
Downside
52 Weeks Volatility :26.0%
Upside
8.32%

Dolby Laboratories (DLB) Returns

Period	Dolby Laboratories, Inc.	Sector (Technology)	Index (Russel 2000)
3 Months	3.63%	-8.0%	0.0%
6 Months	18.8%	8.7%	0.0%
1 Year	0.81%	6.9%	0.0%
3 Years	15.77%	48.0%	-11.6%

Dolby Laboratories (DLB) Key Statistics

in dollars & INR

Previous Close	$80.64
Open	$80.6
Today's High	$82.25
Today's Low	$80.35
Market Capitalization	$7.9B
Today's Volume	$362.3K
52 Week High	$89.66
52 Week Low	$66.35
Revenue TTM	$1.3B
EBITDA	$357.5M
Earnings Per Share (EPS)	$2.7
PE Ratio	30.44
Dividend Yield	1.64%
Profit Margin	19.97%
Quarterly Earnings Growth YOY	0.01%
Return On Equity TTM	10.85%

How to invest in Dolby Laboratories Stock (DLB) from India?

It is very easy for Indian residents to invest directly in Dolby Laboratories from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Dolby Laboratories stock in both Indian Rupees (INR) and US Dollars (USD). Search for Dolby Laboratories or DLB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Dolby Laboratories or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Dolby Laboratories shares which would translate to 0.011 fractional shares of Dolby Laboratories as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Dolby Laboratories, in just a few clicks!

Returns in Dolby Laboratories (DLB) for Indian investors in Rupees

The Dolby Laboratories stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Dolby Laboratories investment value today

Current value as on today

₹1,05,758

Returns

₹5,758

(+5.76%)

Returns from Dolby Laboratories Stock

₹809 (+0.81%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Dolby Laboratories (DLB)

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Dolby Laboratories Stock from India on INDmoney has increased by 3% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Dolby Laboratories

Vanguard Group Inc
7.30%
Morgan Stanley - Brokerage Accounts
7.27%
BlackRock Inc
6.07%
Bank of New York Mellon Corp
5.01%
State Street Corp
2.10%
Mackenzie Investments
2.02%

Analyst Recommendation on Dolby Laboratories

Buy

62%Buy

37%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Dolby Laboratories(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Dolby Laboratories Stock (DLB)

What analysts predicted

Upside of 21.65%

Target:

$100.00

Current:

$82.20

Insights on Dolby Laboratories Stock (Ticker Symbol: DLB)

Price Movement
In the last 3 months, DLB stock has moved up by 3.9%
Increasing Revenue
Revenue is up for the last 3 quarters, 288.81M → 356.99M (in $), with an average increase of 9.9% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, 38.44M → 67.82M (in $), with an average increase of 24.0% per quarter
DLB vs RBA (1 yr)
In the last 1 year, Rb Global Inc has given 33.8% return, outperforming this stock by 33.0%
DLB vs CTAS (3 yr)
In the last 3 years, Cintas Corporation has given 75.3% return, outperforming this stock by 61.8%
Price to Sales
ForDLB every $1 of sales, investors are willing to pay $6.0, whereas for Rb Global Inc, the investors are paying $4.3 for every $1 of sales.

DLB Dolby Laboratories Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$1.2B	↑ 5.95%
Net Income	$255.2M	↑ 108.72%
Net Profit Margin	20.55%	↑ 10.12%

	FY20	Y/Y Change
Revenue	$1.2B	↓ 6.43%
Net Income	$231.4M	↓ 9.32%
Net Profit Margin	19.91%	↓ 0.64%

	FY21	Y/Y Change
Revenue	$1.3B	↑ 10.28%
Net Income	$310.2M	↑ 34.09%
Net Profit Margin	24.21%	↑ 4.3%

	FY22	Y/Y Change
Revenue	$1.3B	↓ 2.14%
Net Income	$184.1M	↓ 40.66%
Net Profit Margin	14.68%	↓ 9.53%

	FY23	Y/Y Change
Revenue	$1.0B	↓ 19.51%
Net Income	$191.5M	↑ 4.01%
Net Profit Margin	18.97%	↑ 4.29%

	FY24	Y/Y Change
Revenue	$1.3B	↑ 26.21%
Net Income	$360.6M	↑ 88.35%
Net Profit Margin	28.31%	↑ 9.34%

	Q3 FY23	Q/Q Change
Revenue	$290.6M	↓ 2.62%
Net Income	$9.2M	↓ 43.98%
Net Profit Margin	3.16%	↓ 2.34%

	Q4 FY23	Q/Q Change
Revenue	$315.6M	↑ 8.61%
Net Income	$67.0M	↑ 629.16%
Net Profit Margin	21.23%	↑ 18.07%

	Q1 FY24	Q/Q Change
Revenue	$364.5M	↑ 15.51%
Net Income	$97.8M	↑ 46.06%
Net Profit Margin	26.84%	↑ 5.61%

	Q2 FY24	Q/Q Change
Revenue	$288.8M	↓ 20.77%
Net Income	$38.4M	↓ 60.7%
Net Profit Margin	13.31%	↓ 13.53%

	Q3 FY24	Q/Q Change
Revenue	$304.8M	↑ 5.54%
Net Income	$58.6M	↑ 52.35%
Net Profit Margin	19.22%	↑ 5.91%

	Q4 FY24	Q/Q Change
Revenue	$357.0M	↑ 17.12%
Net Income	$67.8M	↑ 15.8%
Net Profit Margin	19.0%	↓ 0.22%

	FY19	Y/Y Change
Profit	$1.1B	↑ 3.55%

	FY20	Y/Y Change
Profit	$1.0B	↓ 6.06%

	FY21	Y/Y Change
Profit	$1.2B	↑ 13.39%

	FY22	Y/Y Change
Profit	$1.1B	↓ 3.37%

	FY23	Y/Y Change
Profit	$892.2M	↓ 19.8%

	FY24	Y/Y Change
Profit	$1.1B	↑ 27.02%

	Q3 FY23	Q/Q Change
Profit	$255.0M	↓ 0.72%

	Q4 FY23	Q/Q Change
Profit	$283.5M	↑ 11.18%

	Q1 FY24	Q/Q Change
Profit	$325.7M	↑ 14.9%

	Q2 FY24	Q/Q Change
Profit	$253.2M	↓ 22.28%

	Q3 FY24	Q/Q Change
Profit	$270.8M	↑ 6.97%

	Q4 FY24	Q/Q Change
Profit	$316.2M	↑ 16.77%

	FY19	Y/Y Change
Operating Cash Flow	$327.7M	↓ 6.96%
Investing Cash Flow	$-56.2M	↓ 172.01%
Financing Cash Flow	$-385.3M	↑ 188.32%

	FY20	Y/Y Change
Operating Cash Flow	$343.8M	↑ 4.94%
Investing Cash Flow	$134.4M	↓ 338.98%
Financing Cash Flow	$-207.8M	↓ 46.07%

	FY21	Y/Y Change
Operating Cash Flow	$447.8M	↑ 30.22%
Investing Cash Flow	$-44.9M	↓ 133.42%
Financing Cash Flow	$-252.5M	↑ 21.53%

	FY22	Y/Y Change
Operating Cash Flow	$318.6M	↓ 28.85%
Investing Cash Flow	$-295.9M	↑ 559.02%
Financing Cash Flow	$-610.6M	↑ 141.79%

	FY23	Y/Y Change
Operating Cash Flow	$282.1M	↓ 11.46%
Investing Cash Flow	$54.2M	↓ 118.32%
Financing Cash Flow	$-194.0M	↓ 68.22%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$85.0M	↓ 29.81%
Investing Cash Flow	$-19.7M	↓ 189.47%
Financing Cash Flow	$-42.8M	↑ 16.22%

Dolby Laboratories Technicals Summary

Sell

Neutral

Buy

Dolby Laboratories is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Dolby Laboratories (DLB) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Dolby Laboratories, Inc.	-2.56%	18.8%	0.81%	15.77%	36.05%
Thomson Reuters Corp.	4.72%	4.76%	11.76%	67.52%	149.5%
Copart, Inc.	-5.96%	9.9%	-0.38%	98.5%	186.71%
Global Payments Inc.	-8.88%	-7.97%	-21.82%	-18.24%	-39.13%
Cintas Corporation	2.33%	2.78%	31.22%	121.32%	227.36%
Rb Global Inc	13.16%	19.59%	33.77%	76.45%	165.4%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Dolby Laboratories, Inc.	30.44	30.44	2.08	4.07	0.11	0.06	0.02	26.03
Thomson Reuters Corp.	36.29	36.29	3.64	3.86	0.19	0.06	0.01	26.67
Copart, Inc.	36.66	36.66	3.01	1.57	0.19	0.12	NA	8.61
Global Payments Inc.	16.28	16.28	0.42	12.34	0.07	0.03	0.01	89.59
Cintas Corporation	49.47	49.47	3.78	4.32	0.41	0.15	0.01	10.64
Rb Global Inc	51.1	51.1	0.92	3.78	0.07	0.04	0.01	28.28

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Dolby Laboratories, Inc.	Buy	$7.9B	36.05%	30.44	19.97%
Thomson Reuters Corp.	Hold	$79.2B	149.5%	36.29	30.45%
Copart, Inc.	Buy	$52.4B	186.71%	36.66	32.27%
Global Payments Inc.	Buy	$24.8B	-39.13%	16.28	15.54%
Cintas Corporation	Buy	$82.8B	227.36%	49.47	17.23%
Rb Global Inc	Buy	$18.6B	165.4%	51.1	9.64%

Dolby Laboratories Dividend announcements

Dolby Laboratories Dividends March, 2025
In the quarter ending March,2025. Dolby Laboratories has declared dividend of $0.33

About Dolby Laboratories

Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions primarily for application in the television, broadcast, and live entertainment industries in the United States and internationally. The company develops and licenses its audio technologies, such as AAC, HE-AAC, and extended HE-AAC, a digital audio codec solution; AVC, a digital video codec used in STBs, mobile devices, cameras, and broadcast television services and other products; and Dolby Atmos and Dolby Vision include encoding technologies that artists use to create more compelling and immersive audio and video experiences. Its audio technologies also include DD+, an advanced surround sound audio codec technology; Dolby AC-4, an audio codec that uses cutting edge compression; and HEVC, a next-generation digital video codec that compresses video. In addition, the company offers Dolby Cinemas, a premium large format cinemas that deliver a Dolby branded premium cinema offering with Dolby Vision, Dolby Atmos, and a Dolby theater design; Dolby.io, a next generation SaaS product of immersive, interactive, and social experiences with real-time engagement for live events, especially sports; and digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products for the cinema, television, broadcast, communication, and entertainment industries. Further, it provides various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, and broadcasters. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.

Organization	Dolby Laboratories
Employees	2080
CEO	Mr. Kevin J. Yeaman
Industry	Manufacturing

Management People of Dolby Laboratories

Name	Title
Mr. Kevin J. Yeaman	President, CEO & Director
Mr. Robert J. Park	Senior VP & CFO
Mr. Andy Sherman J.D.	Executive VP, General Counsel & Corporate Secretary
Mr. John D. Couling	Senior Vice President of Entertainment
Dr. Shriram Revankar	Senior Vice President of Advanced Technology Group
Mr. Ryan Nicholson	VP, Corporate Controller & Chief Accounting Officer
Mr. Edwin Marin	Senior VP & Chief Information Officer
Mr. Peter L. Goldmacher	Vice President of Investor Relations
Mr. Todd Pendleton	Senior VP & Chief Marketing Officer
Ms. Linda Rogers	Senior VP & Chief People Officer

Important FAQs about investing in DLB Stock from India :

What is Dolby Laboratories share price today?

Dolby Laboratories share price today stands at $82.20, Open: $80.60 ; Previous Close: $80.64 ; High: $82.25 ; Low: $80.35 ; 52 Week High: $89.66 ; 52 Week Low: $66.35.

The stock opens at $80.60, after a previous close of $80.64. The stock reached a daily high of $82.25 and a low of $80.35, with a 52-week high of $89.66 and a 52-week low of $66.35.

Can Indians buy Dolby Laboratories shares?

Yes, Indians can invest in the Dolby Laboratories (DLB) from India.

With INDmoney, you can buy Dolby Laboratories at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Dolby Laboratories at zero transaction cost.

How can I buy Dolby Laboratories shares from India?

It is very easy to buy Dolby Laboratories from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Dolby Laboratories (DLB) be purchased?

Yes, you can buy fractional shares of Dolby Laboratories with INDmoney app.

What are the documents required to start investing in Dolby Laboratories stocks?

To start investing in Dolby Laboratories, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.